Portal de Periódicos da CAPES

PTEN and PI3K/AKT in Non-Small-Cell Lung Cancer

2015; Future Medicine; Volume: 16; Issue: 16 Linguagem: Inglês

10.2217/pgs.15.122

1744-8042

Cristina Pérez-Ramírez, Marisa Cañadas‐Garre, Miguel Ángel Molina‐Vila, María José Faus-Dáder, Miguel Ángel Calleja‐Hernández,

Cholangiocarcinoma and Gallbladder Cancer Studies

Non-small-cell lung cancer (NSCLC) is the leading cause of cancer deaths worldwide. In the last years, the identification of activating EGFR mutations, conferring increased sensitivity and disease response to tyrosine kinase inhibitors, has changed the prospect of NSCLC patients. The PTEN/PI3K/AKT pathway regulates multiple cellular functions, including cell growth, differentiation, proliferation, survival, motility, invasion and intracellular trafficking. Alterations in this pathway, mainly PTEN inactivation, have been associated with resistance to EGFR-tyrosine kinase inhibitor therapy and lower survival in NSCLC patients. In this review, we will briefly discuss the main PTEN/PI3K/AKT pathway alterations found in NSCLC, as well as the cell processes regulated by PTEN/PI3K/AKT leading to tumorigenesis.